Navigation Links
SemBioSys begins phase I/II trial of insulin produced in plant seeds
Date:12/3/2008

TSX symbol: SBS

CALGARY, Dec. 3 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing protein pharmaceuticals in crop plants, today announced that it has initiated a phase I/II clinical trial of its plant-produced insulin with the first injection of its drug in humans. The trial, taking place in the United Kingdom (UK), will include up to 30 healthy volunteers in a three-arm study (SBS-1000 insulin and two commercial standards) to demonstrate the bioequivalence of safflower-produced insulin to comparator insulin products. Full results are expected to be available during the first half of 2009.

"We have commenced the planned phase I/II clinical trial with plant-made insulin. This is the largest volume biopharmaceutical ever produced in plants," stated Bruce Given, M.D., acting chief medical officer at SemBioSys. "This sophisticated trial is designed to show bioequivalence with respect to insulin concentrations as well as insulin action on blood glucose. Bioequivalence is being measured by comparing SBS-1000 to commercially available insulin currently used to treat diabetes."

"The initiation of the phase I/II clinical trial for plant-produced insulin is a major milestone for SemBioSys. The trial is the first in which plant-produced insulin has been injected into humans and supports the exciting potential for the establishment of plant-produced drugs in the pharmaceutical sector," said Andrew Baum, president and chief executive officer of SemBioSys. "This trial verifies the viability of plant made insulin and defines the regulatory path for plant-made biopharmaceuticals. This trial also represents significant risk reduction for potential large pharmaceutical partners for our insulin and Apo AI Milano programs."

SemBioSys prepared the clinical material in its Current Good Manufacturing Practice (cGMP) compliant manufacturing plant, which underwent a successful cGMP inspection
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
2. SemBioSys announces second quarter 2008 financial and operational results
3. SemBioSys submits IND for safflower-produced insulin to U.S. FDA
4. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
5. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
6. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
7. SemBioSys announces first quarter 2008 financial and operational results
8. SemBioSys receives milestone payments from AVAC Ltd.
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. SemBioSys announces 2007 financial and operational results
11. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... 25, 2015 /CNW/ - The Gairdner Foundation is ... Canada Gairdner Awards, recognizing some of the most significant ... Among the world,s most esteemed medical research ... and provide a $100,000 (CDN) prize to each scientist for ... of research and innovation across the country, inspiring ...
(Date:3/25/2015)... -- FDNA®, the pioneer in computer-aided dysmorphology ... allowing geneticists around the globe to access Facial ... devices. Face2Gene® facilitates detection of facial dysmorphic features and ... up-to-date genetic references. The date of the release coincides ... Salt Lake City, UT , where ...
(Date:3/25/2015)... 25, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , announces ... its target therapy drug candidate ENMD-2076 in triple-negative breast ... of Medical Sciences in Beijing , ...
(Date:3/25/2015)... 2015 Oxis International, Inc. (OXIS) (OXI.PA) a ... announced today Oxis CEO Tony Cataldo will ... at 4:15pm EST to update shareholders and other interested ... Oxis Chairman and CEO Tony Cataldo ... very exciting for Oxis and our shareholders. There is ...
Breaking Biology Technology:2015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 22015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 32015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 42015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 52015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 62015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 72015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 8FDNA Releases a Multi-Platform Version of Face2Gene, a Genetic Search and Reference Solution at ACMG 2015 2CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 2CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 3CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 4CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 5Oxis Biotech Inc. Announces Corporate Update Conference Call for March 31 2
... array microscope slide ... scanner in cytogenetic biodosimetry, TUCSON, Ariz., ... digital pathology systems, the Uniformed,Services University of Health Sciences, ... Jackson Foundation for the Advancement,of Military Medicine (HJF) announced ...
... March 11 On Tuesday, April 22,2008, Wyeth (NYSE: ... 2008 first,quarter. The Company will hold a one-hour conference ... April 22, 2008. Interested investors,and others may listen to ... our,Internet webcast, which may be accessed by visiting our ...
... Inc.,(Nasdaq: MAXY ), a biotechnology company focused ... that it will present at the Cowen &,Company ... 18, 2008 at,8:00 a.m. Eastern Time. Russell Howard, ... of the presentation can be accessed on,Maxygen,s website ...
Cached Biology Technology:DMetrix and the Armed Forces Radiobiology Research Institute Announce Cooperative Research and Development Agreement 2DMetrix and the Armed Forces Radiobiology Research Institute Announce Cooperative Research and Development Agreement 3
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and ... addition of the "Global Iris Recognition Market 2015-2019" ... forecast the Global Iris Recognition market to grow at ... This report covers the present scenario and ... for the period 2015-2019. To calculate the market size, ...
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs , ... company, today announced that the Company will demonstrate multiple ... enterprise and consumers at Connect:ID on March 23 through ... HOYOS Labs will highlight the IEEE Biometric Open Protocol ... ; and enterprise access control system. BOPS was invented ...
(Date:3/20/2015)... March 20, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... one of the products featured in 2015 "I Want ... 11:00 PM EST on the DIY Network.   ... Las Vegas , site of the 2015 International ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... release is available in German . , FRANKFURT. ... birds may serve as a magnetometer to measure the vector ... only as a magnetic compass, which shows the direction of ... neurobiologists Dr.Gerta Fleissner and her husband Prof. Dr. Gnther Fleissner ...
... Scientists seeking answers to the complex problem of premature birth ... labor, study how genetics and the environment interact to cause ... factors that make some women more likely to give birth ... of Dimes. The March of Dimes has committed ...
... expert survivors of the insect world, appear to lack major ... immune system. "It,s surprising," says Emory biologist Nicole Gerardo, ... Biology . "Aphids have some components of an immune system, ... critical to insect immunity." Pea aphids are major agricultural ...
Cached Biology News:A magnetometer in the upper beak of birds? 2A magnetometer in the upper beak of birds? 3March of Dimes provides $2.6 million in new funding for preterm birth research 2Pesky aphid thrives despite weak immune system 2
PTFE/red rubber septum silver aluminum seal ,11 mm seal diam. ...
...
... The Thermo Labsystems Wellmix is a ... and time settings. The shaking speed is ... shaking frequency, high speed and a small ... assays. The shaking time is quick and ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
Biology Products: